TILT Biotherapeutics (private company)

See something wrong or missing? Let us know
Offices:Helsinki
Business model:B2B

TILT Biotherapeutics Ltd is a preclinical stage company working in the field of cancer immunotherapy. TILT aims to translate its unique approach into clinical trials.

The company’s patented technology involves utilization of oncolytic viruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR) and checkpoint inhibiting antibody therapy.

The TILT approach has the potential to achieve similar results in CAR therapy of  solid tumors as currently achieved for CD19+ hematological tumors.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 15.69M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to TILT Biotherapeutics

Name Criteria
Finland Oura Health
60%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Lifeline Ventures
  • At least one other investor: Business Finland
  • Total raised in a similar range: 10M+ USD
Finland Synoste Oy
60%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Lifeline Ventures
  • At least one other investor: Business Finland
  • Total raised in a similar range: 10M+ USD
Finland Solar Foods
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Lifeline Ventures
  • Total raised in a similar range: 10M+ USD
Finland Valkee
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Lifeline Ventures
  • Total raised in a similar range: 10M+ USD
United Kingdom Abzena
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
United Kingdom Achilles Therapeutics
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Germany Adrenomed AG
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Denmark AFYX Therapeutics
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Spain Algenex
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Iceland Alvotech
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Top